Ryligency 20 mg/ml

Ryligency 20 mg/ml is a medicine authorised by Swissmedic under authorisation number 69478. The authorisation holder is Aguettant Suisse SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 May 2024 and the authorisation is limited until 01 May 2029. ATC code C01BB01 places the medicine in the group Cardiac therapy.

  • Dispensing category B
  • Authorisation number 69478
  • ATC C01BB01
  • Synthetic medicines
Authorisation data
Authorisation number69478
NameRyligency 20 mg/ml
Full nameRyligency 20 mg/ml, solution injectable en seringue préremplie
Authorisation holderAguettant Suisse SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC01BB01
First authorisation02 May 2024
Authorisation validity01 May 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Ryligency 20 mg/ml, solution injectable en seringue préremplieB02 May 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)C01BB0102.02.0.B
210Fertigspritze(n)C01BB0102.02.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ryligency 20 mg/ml authorised in Switzerland?

Yes. Ryligency 20 mg/ml is authorised by Swissmedic under authorisation number 69478, data as of 01 September 2026. The authorisation is limited until 01 May 2029.

Which dispensing category does Ryligency 20 mg/ml have?

Ryligency 20 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ryligency 20 mg/ml?

The authorisation holder is Aguettant Suisse SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com